Blood Res.  2013 Mar;48(1):3-4. 10.5045/br.2013.48.1.3.

Blood Research: a new journey of passion with harmony beyond Asia onto the world

• Koo HH

• KMID: 2270716
• DOI: http://doi.org/10.5045/br.2013.48.1.3

Abstract

No abstract available.

MeSH Terms

Asia

Reference

1. Kwon SW. The KJH: Sailing over the horizon. Korean J Hematol. 2010; 45:77–78. PMID: 21120180.

2. Lee JH, Joo YD, Kim H, et al. Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine. J Clin Oncol. 2013; 31:701–709. PMID: 23129746.

3. Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study. J Clin Oncol. 2009; 27:6027–6032. PMID: 19884539.

4. Eom HS, Kim YK, Chung JS, et al. Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP). Ann Hematol. 2010; 89:489–497. PMID: 20012045.

5. Yoo KH, Lee SH, Sung KW, et al. Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. Am J Hematol. 2011; 86:12–17. PMID: 21064135.